Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...

s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Immunology is one of the most profitable disease areas for pharma, with several of the world’s best-selling drugs falling under its umbrella. But it is also facing more disruption than most ...

Survey results show that clinicians largely disagree about choices for severe asthma treatment, due primarily to a lack of ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

MoonLake, a clinical-stage biopharma company developing immunology therapeutics, was created by an April 2022 merger with ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Its immunology franchise sales reached about $ ... These next-generation drugs often have competitive advantages in efficacy and safety profiles relative to those being developed by competitors ...